Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma
- Michael J. Robertson
- , Brad S. Kahl
- , Julie M. Vose
- , Sven De Vos
- , Mary Laughlin
- , Patrick J. Flynn
- , Kendrith Rowland
- , Jose C. Cruz
- , Stuart L. Goldberg
- , Luna Musib
- , Christelle Darstein
- , Nathan Enas
- , Jeffery L. Kutok
- , Jon C. Aster
- , Donna Neuberg
- , Kerry J. Savage
- , Ann LaCasce
- , Donald Thornton
- , Christopher A. Slapak
- , Margaret A. Shipp
Research output: Contribution to journal › Article › peer-review
235
Link opens in a new tab
Scopus
citations